Valsartan: 46.7%~48.6%, Sacubitril: 44.1%~45.9%, Sacubitril/Valsartan Sodium: 98.0%~102.0% Sacubitril/Valsartan Sodium contains not less than 98.0% and not more than 102.0% of C48H60N6Na3O10.5, calculated on the dried substance.

共有 1 個藥物證書使用此成份

琥醯聯苯壓利-纈戊醯拮壓鈉鹽
Sacubitril Valsartan Sodium

• 申請商: 西海生技股份有限公司
• 適應症: 治療慢性心衰竭
• 發證日期: 2024-01-02